Skip to main content
Immunology logoLink to Immunology
. 1980 Jan;39(1):1–9.

Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.

D C Henderson, D Parker, J L Turk
PMCID: PMC1457770  PMID: 7380461

Abstract

A comparison was made in mice between resistance to growth of a syngeneic methylcholanthrene-induced fibrosarcoma (Meth A) and specific delayed-type hypersensitivity to this tumour. Resistance could be induced in 90% of mice following a single injection of 10(4) Meth A cells. This resistance could be transferred by spleen cells but not serum. Delayed skin reactivity to ultrasonicated Meth A cells was found in both tumour-resistant and tumour-bearing mice and could be passively transferred by spleen cells and serum. These findings suggest a dissociation between tumour resistance and specific delayed-type hypersensitivity. It would appear that, in this system, delayed skin reactivity to Meth A tumour cells is mediated by humoral antibody despite a mononuclear cell infiltrate at 24 and 48 h and that this could be the reason for its lack of correlation with host resistance to tumour growth which is cell-mediated and not transferable by serum.

Full text

PDF
1

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein I. D., Zbar B., Rapp H. J. Impaired inflammatory response in tumor-bearing guinea pigs. J Natl Cancer Inst. 1972 Dec;49(6):1641–1647. doi: 10.1093/jnci/49.6.1641. [DOI] [PubMed] [Google Scholar]
  2. Bolton P. M., Mander A. M., Davidson J. M., James S. L., Newcombe R. G., Hughes L. E. Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers. Br Med J. 1975 Jul 5;3(5974):18–20. doi: 10.1136/bmj.3.5974.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burdick J. F., Wells S. A., Jr, Herberman R. B. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. Surg Gynecol Obstet. 1975 Nov;141(5):779–794. [PubMed] [Google Scholar]
  4. Char D. H., Lepourhiet B. G., Herberman R. B. Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia. Int J Cancer. 1973 Sep 15;12(2):409–419. doi: 10.1002/ijc.2910120212. [DOI] [PubMed] [Google Scholar]
  5. Harris J., Bagai R. C. Immune deficiency states associated with malignant disease in man. Med Clin North Am. 1972 Mar;56(2):501–514. doi: 10.1016/s0025-7125(16)32410-5. [DOI] [PubMed] [Google Scholar]
  6. Henderson D. C., Chang R. W., Turk J. L. Infection with LDH virus alters host response to tumours. Br J Cancer. 1979 Apr;39(4):453–456. doi: 10.1038/bjc.1979.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Herberman R. B., Hollinshead A. C., Alford T. C., McCoy J. L., Halterman R. H., Leventhal B. G. Delayed cutaneous hypersensitivity reactions to extracts of human tumors. Natl Cancer Inst Monogr. 1973 Jun;37:189–195. [PubMed] [Google Scholar]
  8. Hulliger L., Blazkovec A. A., Sorkin E. A study of the passive cellular transfer of local cutaneous hypersensitivity. IV. Transfer of hypersensitivity to sheep erythroytes with peritoneal exudate cells passively coated with antibody. Int Arch Allergy Appl Immunol. 1968;33(3):281–291. doi: 10.1159/000230045. [DOI] [PubMed] [Google Scholar]
  9. Jessup J. M., Cohen M. H., Tomaszewski M. M., Felix E. L. Effects of murine tumors on delayed hypersensitivity to dinitrochlorobenzene. I. Description of anergy caused by transplanted tumors. J Natl Cancer Inst. 1976 Nov;57(5):1077–1084. doi: 10.1093/jnci/57.5.1077. [DOI] [PubMed] [Google Scholar]
  10. Johnson M. W., Maibach H. I., Salmon S. E. Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response? N Engl J Med. 1971 Jun 3;284(22):1255–1257. doi: 10.1056/NEJM197106032842210. [DOI] [PubMed] [Google Scholar]
  11. Kerckhaert J. A., Van den Berg G. J., Willers J. M. Influence of cyclophosphamide on the delayed hypersensitivity of the mouse. Ann Immunol (Paris) 1974 Mar-Apr;125(3):415–426. [PubMed] [Google Scholar]
  12. Nelson M., Nelson D. S. Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages. Immunology. 1978 Feb;34(2):277–290. [PMC free article] [PubMed] [Google Scholar]
  13. Oren M. E., Herberman R. B. Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells. Clin Exp Immunol. 1971 Jul;9(1):45–56. [PMC free article] [PubMed] [Google Scholar]
  14. Turk J. L., Parker D., Poulter L. W. Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology. 1972 Oct;23(4):493–501. [PMC free article] [PubMed] [Google Scholar]
  15. Zembala M., Asherson G. L. Contact sensitivity in the mouse. V. The role of macrophage cytophilic antibody in passive transfer and the effect of trypsin and anti-gamma globulin serum. Cell Immunol. 1970 Sep;1(3):276–289. doi: 10.1016/0008-8749(70)90049-3. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES